within Pharmacolibrary.Drugs.ATC.L;

model L04AC18
  extends Pharmacokinetic.Models.PK_1C_enteral(
    weight         = 70,
    F              = 0.89,
    Cl             = 0.005166666666666667,
    adminDuration  = 600,
    adminMass      = 0.15,
    adminCount     = 1,
    Vd             = 0.0112,
    Cmin           = 0.001,
    Cmax           = 0.01,
    Ctox_peak      = 0.02,
    Ctox_trough    = 0.01,
    ka             = 0.0,
    Tlag           = 0
  );

  annotation(Documentation(
    info ="<html><body><p>Risankizumab is a humanized immunoglobulin G1 monoclonal antibody targeting the p19 subunit of interleukin-23 (IL-23). It is used for the treatment of moderate to severe plaque psoriasis, and is approved for this indication in several regions including the US and EU.</p><h4>Pharmacokinetics</h4><p>Pharmacokinetic parameters reported for adult patients with moderate to severe plaque psoriasis after subcutaneous administration.</p><h4>References</h4><ol><li><p>Pang, Y, et al., &amp; Othman, AA (2020). Clinical Pharmacokinetics and Pharmacodynamics of Risankizumab in Psoriasis Patients. <i>Clinical pharmacokinetics</i> 59(3) 311–326. DOI:<a href=&quot;https://doi.org/10.1007/s40262-019-00842-5&quot;>10.1007/s40262-019-00842-5</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/31758502/&quot;>https://pubmed.ncbi.nlm.nih.gov/31758502</a></p></li><li><p>Thakre, N, et al., &amp; Pang, Y (2024). Population Pharmacokinetic and Exposure-Response Modeling to Inform Risankizumab Dose Selection in Patients With Ulcerative Colitis. <i>Clinical pharmacology and therapeutics</i> 116(3) 847–857. DOI:<a href=&quot;https://doi.org/10.1002/cpt.3330&quot;>10.1002/cpt.3330</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/38863178/&quot;>https://pubmed.ncbi.nlm.nih.gov/38863178</a></p></li><li><p>Thakre, N, et al., &amp; Suleiman, AA (2022). Population Pharmacokinetics and Exposure-Response Analyses for Risankizumab in Patients with Active Psoriatic Arthritis. <i>Rheumatology and therapy</i> 9(6) 1587–1603. DOI:<a href=&quot;https://doi.org/10.1007/s40744-022-00495-0&quot;>10.1007/s40744-022-00495-0</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/36178584/&quot;>https://pubmed.ncbi.nlm.nih.gov/36178584</a></p></li></ol></body></html>",
    revisions = "<html><body><ul><li>06/2025 model generated by LLM gpt-4.1, references by scholarly and scripts created by Tomas Kulhanek</li></ul></body></html>"
  ));
end L04AC18;
